Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vincerinone in Children With Pearson Syndrome
NCT02104336Phase 2Terminated
- Sponsor
- Bioelectron
- Start
- Aug 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatiquinone in Pearson syndrome, sponsored by Bioelectron. Started Aug 2014; status: terminated.
02
Drugs
vatiquinone
03
Conditions
Pearson syndrome
Beyond the preview
Go deeper on NCT02104336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104336.